Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20

Showing 20 citing articles:

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Tianye Li, Mengke Niu, Jianwei Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Novel immune checkpoint targets: A promising therapy for cancer treatments
Mohsina Patwekar, Nouroz Sehar, Faheem Patwekar, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111186-111186
Closed Access | Times Cited: 20
Immunotherapy for colorectal cancer: insight from inherited genetics
Nijole P. Tjader, Amanda E. Toland
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 444-456
Closed Access | Times Cited: 6
Immune checkpoint blockade in hematological malignancies: current state and future potential
Prateek Pophali, Juan Carlos Varela, Jacalyn Rosenblatt
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Advances in Antibody-Based Immune-Stimulating Drugs: Driving Innovation in Cancer Therapy
R R Zhao, Xing-Xing Fan
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1440-1440
Open Access
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
Miaomiao Chen, Yuli Zhou, Kelvin K H Bao, et al.
BioDrugs (2025)
Closed Access
Firing up “cold” tumors: Ferroptosis causes immune activation by improving T cell infiltration
Xinru Li, Yawen Li, Halahati Tuerxun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117298-117298
Open Access | Times Cited: 4
Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?
Jinming Liu, Biao Zhang, Guolin Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The role of transforming growth factor-β (TGF-β) in the formation of exhausted CD8 + T cells
Rong Ma, Jinhan Sun, Yanyang Wang
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma
Wei Yan, Dean Rao, Feimu Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy
Fangrui Zhao, Chen Zhao, Tangpeng Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Introduction of Carbonyl Groups into Antibodies
Evgeny L. Gulyak, Vera A. Alferova, Vladimir A. Korshun, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7890-7890
Open Access | Times Cited: 4
Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1
Irene Cattaneo, Sylvie Choblet, Rut Valgardsdottir, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 15-15
Open Access | Times Cited: 1
Copper homeostasis and cuproptosis in gynecological cancers
Xiaodi Huang, Mengyi Lian, Changzhong Li
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Exploring the potential of TGFβ as a diagnostic marker and therapeutic target against cancer
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Biochemical Pharmacology (2024) Vol. 231, pp. 116646-116646
Open Access | Times Cited: 1
Structural basis for bispecific antibody design: arrangement of domain linkage produces activity enhancement
K Sato, Shiro Uehara, Atsushi Tsugita, et al.
(2024)
Closed Access
From immune equilibrium to tumor ecodynamics
Xiaoping Chen
Frontiers in Oncology (2024) Vol. 14
Open Access
Virally induced colorectal cancer drug resistance
Zilungile L. Mkhize‐Kwitshana, Pragalathan Naidoo, Roxanne Pillay, et al.
Elsevier eBooks (2024), pp. 383-424
Closed Access
Page 1

Scroll to top